Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. 13 January 2020. Philip Nelson.

Executive Summary

Draft legislation designed to make it easier for companies to gain patents for medical software is likely to make a comeback in the US Congress this year. Proponents of the bill say it will reverse a trend set by a six-year-old Supreme Court case that virtually made it impossible to get software patents. See what attorney Philip Nelson said about it here.

If the bill passes, “it’ll be much easier for start-ups to get their software-related or medical device software patents. Smart devices are the way of the future. And it’s ironic because it’s almost like [software] is a poison pill or some kind of taint on your technology.” – Philip Nelson, patent attorney, Knobbe Martens

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel